IgG4 antibody repertoire diversity is stable over several years in health and autoimmune disease
- 1Leiden University Medical Center
Abstract
Despite its relative anti-inflammatory nature, IgG4 is involved in a variety of pathological conditions such as autoimmune disease and cancer. To investigate whether the IgG4 repertoire presents any abnormalities in diseases where IgG4 autoantibodies predominate, we charted longitudinal IgG4 repertoires in health, in an IgG4-mediated autoimmune disease (AID; muscle-specific kinase myasthenia gravis (MuSK MG)), and in IgG1/IgG3 mediated AIDs (acetylcholine receptor (AChR) MG and Lambert-Eaton myasthenic syndrome (LEMS). In total, we assessed 218 samples of 69 donors using mass spectrometry-based antibody repertoire analysis, covering a timespan of up to eight years. Despite being superficially inconspicuous in clonal diversity and abundances, we detected a slightly elevated number of IgG4 clones in MuSK MG patients compared to healthy donors. Notably, this observation did not coincide with drastic repertoire changes during treatment, suggesting that a large portion of the IgG4 repertoire is not significantly affected by common MuSK MG treatment regimens. Comparing the IgG4 antibody repertoires of all donors, we found that they were exceptionally unique for each individual. Against what would be expected in the case of a constantly adapting antibody repertoire, a large portion of the IgG4 clones remained stable without any further maturation. This observation even extended to patients receiving B cell depleting or IgG modulating treatments. Our findings suggest that a dominating fraction of the IgG4 pool may be produced by long-lived plasma cells, which are unaffected by disease or medical interventions.
Related
- CD19-CAR T-cell therapy resets the EBV+ autoreactive B cell repertoire in autoimmune disease
- Evaluation of anti-nuclear antibody patterns and their associations with autoimmune disease biomarkers
- Microbial diversity, safety, and quality challenges of several commercial plant-based meat products in Thailand
- 793 PD1 expression in LAG3+ exhausted T cells restrains memory recall responses through a mechanism involving TCR repertoire diversity and non CD8+ T cell populations
- DDOX expands the repertoire of tetracyclines for Parkinson’s disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils
BibTeX
@misc{wollenweber2026igg4,
title = {{IgG4 antibody repertoire diversity is stable over several years in health and autoimmune disease}},
author = {L. Wollenweber and L. M. Paardekooper and Y. J. M. Campman and J. M. van Bokkum and M. R. Tannemaat and J. J. G. M. Verschuuren and A. Barendregt and A. J. R. Heck and A. Bondt and M. G. Huijbers},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.30.755566},
url = {https://www.biorxiv.org/content/10.64898/2026.09.30.755566v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - IgG4 antibody repertoire diversity is stable over several years in health and autoimmune disease
AU - L. Wollenweber
AU - L. M. Paardekooper
AU - Y. J. M. Campman
AU - J. M. van Bokkum
AU - M. R. Tannemaat
AU - J. J. G. M. Verschuuren
AU - A. Barendregt
AU - A. J. R. Heck
AU - A. Bondt
AU - M. G. Huijbers
PY - 2026
DA - 2026/09/30
PB - bioRxiv
DO - 10.64898/2026.09.30.755566
UR - https://www.biorxiv.org/content/10.64898/2026.09.30.755566v1
AB - Despite its relative anti-inflammatory nature, IgG4 is involved in a variety of pathological conditions such as autoimmune disease and cancer. To investigate whether the IgG4 repertoire presents any abnormalities in diseases where IgG4 autoantibodies predominate, we charted longitudinal IgG4 repertoires in health, in an IgG4-mediated autoimmune disease (AID; muscle-specific kinase myasthenia gravis (MuSK MG)), and in IgG1/IgG3 mediated AIDs (acetylcholine receptor (AChR) MG and Lambert-Eaton myasthenic syndrome (LEMS). In total, we assessed 218 samples of 69 donors using mass spectrometry-based antibody repertoire analysis, covering a timespan of up to eight years. Despite being superficially inconspicuous in clonal diversity and abundances, we detected a slightly elevated number of IgG4 clones in MuSK MG patients compared to healthy donors. Notably, this observation did not coincide with drastic repertoire changes during treatment, suggesting that a large portion of the IgG4 repertoire is not significantly affected by common MuSK MG treatment regimens. Comparing the IgG4 antibody repertoires of all donors, we found that they were exceptionally unique for each individual. Against what would be expected in the case of a constantly adapting antibody repertoire, a large portion of the IgG4 clones remained stable without any further maturation. This observation even extended to patients receiving B cell depleting or IgG modulating treatments. Our findings suggest that a dominating fraction of the IgG4 pool may be produced by long-lived plasma cells, which are unaffected by disease or medical interventions.
ER -